Carolyn Vega

About Carolyn Vega

30M in combined diagnostic sales. I build enterprise commercial motions from scratch in white space, in regulated markets, where the channel is still forming. What I do: I enter complex organizations as a business partner, not a vendor. I translate clinical and financial complexity into clear decisions, earn trust at the C-suite level, and expand from the initial entry point across the full enterprise umbrella. Healthcare: → #1 Lucira sales leader nationally - outperforming CVS, McKesson, Cardinal Health, and Walgreens → Co-founded Epimedi, closed Pfizer as sole authorized OTC distributor - selected over every national distributor in the country on track record alone | Outperformed Pfizer\'s own Amazon listing | B2B and B2C clients → Led enterprise GTM for 3EO molecular diagnostics developed with the Harvard Wyss Institute → Already leading BinaxNOW enterprise sales when eMed (now a $2B+ employer health company) selected Peach Medical as their commercialization partner. Brokered eMed\'s SaaS-enabled proctored diagnostic platform into my existing book, building testing protocols and implementation blueprints across mid-market to global, multi-entity organizations Enterprise book spans: Fortune 500+ · Self-insured employers (1K+ lives) · Top-tier universities · Health systems · Film/TV/Broadway production · Federal & state government · UHNW family offices · Mission-driven orgs · B2B and B2C clients Entrusted to open and bring FENDI to flagship status in its first year. Developed a client program adopted across the broader LVMH portfolio - awarded Entrepreneur of the Year by FENDI/LVMH (Forbes Global #47) and recognized top 10 globally at FENDI LVMH Privé.My expertise spans: Employer Health Strategy · Preventive Care · Enterprise Diagnostics · Benefits & HR Leadership · Executive Sales · SaaS Platform Commercialization · FDA-Regulated Markets Based in Miami.

Experience

1. Enterprise Account Executive

   Epimedi

   Sep 2023 — Present · Miami, FL, US

   Co-founded Epimedi and closed Pfizer directly as their sole authorized OTC molecular distributor - selected over every national distributor in the country on track record alone. Served as the trusted face and voice of Pfizer\'s product to the market, operating as the exclusive broker between a major pharmaceutical brand and the enterprise buyer. Outperformed national distributors including Thermo Fisher Scientific, Henry Schein, McKesson, and Cardinal Health within the first year of launch. Outperformed Pfizer\'s own Amazon listing.Positioned Epimedi as the definitive go-to broker for molecular diagnostics - brokering premium, regulated health products directly into Fortune 500 corporations, self-insured employer groups of employees, UHNW family offices, and mission-driven institutions. Built and expanded a client book spanning NBCUniversal/Comcast (Fortune #28), Honeywell (Fortune #120), Warner Bros. Discovery (Fortune #115), LAM Research (Fortune #295), Laurene Powell Jobs\' Emerson Collective, and Chan Zuckerberg\'s CZ Biohub.Owned full-cycle enterprise sales - prospecting through close, navigating multi-layered decision structures across large, multi-site organizations, and expanding across business units and geographic locations. Engaged directly with CHROs, CFOs, HR leaders, and executive stakeholders, aligning molecular diagnostic programs with workforce risk mitigation and benefits strategy objectives. Achieved a 9-in-10 close rate with a sub-30-day average sales cycle.Established CRM discipline and sales enablement frameworks across distributor teams - driving forecasting accuracy and top-quartile close rates.

Education

• The Art Institute of Philadelphia

  Coursework toward Associate’s Degree (transferred credits)

• Rowan College at Burlington County

  Coursework toward Associate’s Degree (transferred credits)

• Miami International University of Art & Design

  Bachelor of Fine Arts Degree